BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31511581)

  • 1. The association of integration patterns of human papilloma virus and single nucleotide polymorphisms on immune- or DNA repair-related genes in cervical cancer patients.
    Joo J; Omae Y; Hitomi Y; Park B; Shin HJ; Yoon KA; Sawai H; Tsuiji M; Hayashi T; Kong SY; Tokunaga K; Kim JY
    Sci Rep; 2019 Sep; 9(1):13132. PubMed ID: 31511581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
    Liu Y; Lu Z; Xu R; Ke Y
    Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Kamal M; Lameiras S; Deloger M; Morel A; Vacher S; Lecerf C; Dupain C; Jeannot E; Girard E; Baulande S; Dubot C; Kenter G; Jordanova ES; Berns EMJJ; Bataillon G; Popovic M; Rouzier R; Cacheux W; Le Tourneau C; Nicolas A; Servant N; Scholl SM; Bièche I;
    Br J Cancer; 2021 Feb; 124(4):777-785. PubMed ID: 33191407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
    Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
    Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology.
    Nkili-Meyong AA; Moussavou-Boundzanga P; Labouba I; Koumakpayi IH; Jeannot E; Descorps-Declère S; Sastre-Garau X; Leroy EM; Belembaogo E; Berthet N
    Sci Rep; 2019 Feb; 9(1):1504. PubMed ID: 30728408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.
    Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X
    J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of HPV physical status and integration sites in cervical cancer.
    Nambaru L; Meenakumari B; Swaminathan R; Rajkumar T
    Asian Pac J Cancer Prev; 2009; 10(3):355-60. PubMed ID: 19640172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
    Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the HPV integration and its progression to cervical cancer.
    Oyervides-Muñoz MA; Pérez-Maya AA; Rodríguez-Gutiérrez HF; Gómez-Macias GS; Fajardo-Ramírez OR; Treviño V; Barrera-Saldaña HA; Garza-Rodríguez ML
    Infect Genet Evol; 2018 Jul; 61():134-144. PubMed ID: 29518579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions.
    Wang L; Shen H; Feng B; Zhu D; Yu L; Tian X; Ren C; Gao C; Li X; Ma D; Hu Z; Wang H
    PLoS One; 2017; 12(4):e0175520. PubMed ID: 28414756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of integrated HPV58 sequences in cervical lesions.
    Li H; Zhang R; Cai Y; Li Y; Cheng X; Zhu B; Yang Y; Xiang Y
    Int J Gynecol Cancer; 2012 Sep; 22(7):1234-7. PubMed ID: 22801029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration rates of human papilloma virus genome in a molecular survey on cervical specimens among Iranian patients.
    Karbalaie Niya MH; Mobini Kesheh M; Keshtmand G; Basi A; Rezvani H; Imanzade F; Panahi M; Rakhshani N
    Eur J Cancer Prev; 2019 Nov; 28(6):537-543. PubMed ID: 30444753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of gene function as a consequence of human papillomavirus DNA integration.
    Schmitz M; Driesch C; Beer-Grondke K; Jansen L; Runnebaum IB; Dürst M
    Int J Cancer; 2012 Sep; 131(5):E593-602. PubMed ID: 22262398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Profiling of Human Papillomavirus DNA Integration into Human Genome and Its Influence on PD-L1 Expression in Chinese Uygur Cervical Cancer Women.
    Yang-Chun F; Sen-Yu W; Yuan Z; Yan-Chun H
    J Immunol Res; 2020; 2020():6284960. PubMed ID: 32411801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.
    Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M
    Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
    Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
    Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.
    Li W; Wang W; Si M; Han L; Gao Q; Luo A; Li Y; Lu Y; Wang S; Ma D
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1355-61. PubMed ID: 18478264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.
    Futai M; Watanabe J; Jobo T; Tsunoda S; Nishimura Y; Watanabe K; Okayasu I; Unno N
    Int J Gynecol Cancer; 2009 Nov; 19(8):1396-401. PubMed ID: 20009896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
    Koopman LA; Szuhai K; van Eendenburg JD; Bezrookove V; Kenter GG; Schuuring E; Tanke H; Fleuren GJ
    Cancer Res; 1999 Nov; 59(21):5615-24. PubMed ID: 10554043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.